Sentinel lymph node biopsy for lymphophilic conjunctival and eyelid tumours: Apropos of 8 cases;Biopsie du ganglion sentinelle dans les tumeurs lymphophiles conjonctivales et palpébrales: À propos de 8 cas

Revue de Laryngologie Otologie Rhinologie

Volumn 130, Issue 4-5, 2009, Pages 231-234

  Maalouf, T ^a   George, J L ^a   Geoffrois, L ^b   Olivier, P ^a   Dolivet, G ^b  

^a CHU NANCY BRABOIS   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

Author keywords

Conjunctive; Eyelid; Lymphoscintigraphy; Melanoma; Sentinel node biopsy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER MORTALITY; CANCER SURGERY; CARCINOMA; CLINICAL ARTICLE; CONJUNCTIVA TUMOR; EPIDERMOID TUMOR; EYELID TUMOR; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPHOSCINTIGRAPHY; MELANOMA; MERKEL CELL TUMOR; NECK DISSECTION; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; SENTINEL LYMPH NODE BIOPSY;

CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; CONJUNCTIVAL NEOPLASMS; EYELID NEOPLASMS; HUMANS; MELANOMA; SENTINEL LYMPH NODE BIOPSY;

EID: 77954007028     PISSN: 00351334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. TUOMAALA S, KIVELA T. Metastatic pattern and survival in disseminated conjunctival melanoma: Implications for sentinel lymph node biopsy. OPHTHALMOLOGY. 2004;111:816-22.
2. BERNARDINI FP. Management of malignant and benign eyelid lesions. CURR OPIN OPHTHALMOL. 2006;17:480-4.
3. PARIDAENS ADA, MINASSIAN DC, MCCARTNEY ACE, HUNGERFOLD JL. Prognostic factors in primary malignant melanoma of the conjunctiva: A clinicopathological study of 256 cases. BR J OPHTHALMOL. 1994;78:252-9.
4. ESMAELI B, EISHER S, POPP J, DELPASSAND E, PRIETO VG, GERSHENWALD JE. Sentinel lymph node biopsy for conjuntival melanoma. OPHTHALMIC PLASTIC RECONSTR SURG. 2001;6:436-42.
5. COOK BE, BARTLEY GB. Treatment options and future prospects for the management of eyelid malignancies. OPHTHALMOLOGY. 2001;108:2088-2100.
6. SHIELDS CL, SHIELDS JA, GUNDUZ K, CATER J, MERCADO GV, GROSS N, LALLY B. Conjunctival melanoma risk factors for recurrence, exenteration, metastasis and death in 150 consecutive patients. ARCH OPHTHALMOL. 2000;118:1497-1507.
7. SHERMAN DD, GONNERING RS, WALLON JH, LEMKE BN, DOOS WG, DORTZBACH RK, LYON DB, BINDLEY CD. Identification of orbital lymphatics: Enzyme hitochemical light microscopic and electron microscopic studies. OPHTHAL PLAST RECONSTR SURG. 1993;9:153-69.
8. PITMAN KT, JOHNSON JT, BROWN ML, MYERS EN Sentinel lymph node biopsy in head and neck squamous cell carcinoma. LARYNGOSCOPE. 2002 Dec;112(12):2101-13.
9. LYNN QUAN M, MC CREADY D. The evolution of lymph node assessment in brest cancer. J SURG ONCOL. 2008; 1-5.
10. WANG JD, DENG XC, JIN XJ, ZHANG C, ZHOU JQ, ZHOU QY, LIU J, QIAN MF. Exploration chirurgicale des ganglions sentinelles dans le cancer papillaire de la thyroïde. REV LARYNGOL OTOL RHINOL. 2008;4:285-87.
11. NAHABEDIAN MY, TUFARO AP, MANSON PN. Sentinel lymph node biopsy for the T1 (thin) melanoma: Is it necessary? ANN PLAST SURG. 2003;6:601-6.
12. CECCHI R, DE GAUDIO C, BURALLI L, INNOCENTI S. Lymphatic mapping and sentinel lymph node biopsy in the management of primary cutaneous melanoma: Report of a single centre experience. TUMORI. 2006;2:113-7.
13. HO VH, ROSS MI, PRIETO VG, KHALEEP A, KIM S, ESMAELI B. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. ARCH OTOLARYNGOL HEAD NECK SURG. 2007;8:820-26.
14. MORTON DL, THOMPSON JF, COCHRAN AJ, MOZZILLO N, ELASHOFF R, ESSNER R, NIEWEG OE, ROSES DF, HOEKSTRA HJ, KARAKOUSIS CP, REINTGEN DS, COVENTRY BJ, GLASS EC, WANG HJ, MSLT Group. Sentinel node biopsy or nodal observation in melanoma. N ENGL J MED. 2006;13:1307-17.
15. WAGNER JD, SCHAUWECKER D, DAVIDSON D, LOGAN T, COLEMAN JJ, HUTCHINS G, LOVE C, WENK S, DAGGY J. Inefficacy of F 18 Fluorodeoxy-D-glucose positon emission tomography scans for initial evaluation in early stage cutaneous melanoma. CANCER. 2005;104:570-9.
16. KURLI M, CHIN K, FINGER PT. Whole body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma. BR J OPHTHALMOL. 2008;92:479-82.
17. ESMAELI B. Regional lymph node assessment for conjunctival melanoma: Sentinel lymph node biopsy and positron emission tomography. B J OPHTHALMOL. 2008;92:443-45.
18. BALLO MT, ROSS MI, CORMIER JN, MYERS JN, LEE JE, GERSHENWALD JE, HWU P, ZAGARS GK. Combined modality therapy for patients with regional nodal metastases for melanoma. INT J RADIAT ONCOL BIOL PHYS. 2006;1:106-13.
19. ANG KK, PETERS LJ, WEBER RS, MORRISON WH, FRANKENTHALER RA, GARDEN AS, GOEPFERT H, HA CS, BYERS RM. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. INT J RADIAT ONCOL BIOL PHYS. 1994;4:795-8.
20. BONNEN MD, BALLO MT, MYERS JN, GARDEN AS, DIAZ EM JR, GERSHENWALD JE, LEE JE, OSWALD MJ, ROSS MI, ANG KK. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. CANCER. 2004;2:383-9.
21. WARNER RE, QUlNN MJ, HRUBY G, SCOLYER RA, UREN RF, THOMPSON JF. Management of Merkel Cell Carcinoma: The roles of lymphoscintigraphy, sentinel node biopsy and adjuvant radiotherapy. ANN SURG ONCOL. 2008-07-30.